General Information of DTT (ID: TT9QBI6)

DTT Name Phosphoinositide dependent protein kinase-1 (PDPK1) DTT Info
UniProt ID
PDPK1_HUMAN
Gene Name PDPK1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Investigative Drug(s)
Clinical Trial Drug(s)
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
AR-12 DM4RK6P Lymphoma 2A80-2A86 Phase 1 [1]
------------------------------------------------------------------------------------
7 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
BX-795 DMRIMLJ Discovery agent N.A. Investigative [2]
BX-912 DMZA45C Discovery agent N.A. Investigative [2]
GSK-2334470 DM3BI7R Solid tumour/cancer 2A00-2F9Z Investigative [3]
L-serine-O-phosphate DMTJ1NH Discovery agent N.A. Investigative [4]
PF-5177624 DMUOFT0 Solid tumour/cancer 2A00-2F9Z Investigative [5]
PHT-427 DMI96Y3 Discovery agent N.A. Investigative [6]
PMID20005102C1 DMMESBW Discovery agent N.A. Investigative [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Investigative Drug(s)
Molecule Interaction Atlas

References

1 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
2 Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1. J Biol Chem. 2005 May 20;280(20):19867-74.
3 Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma. Oncogene. 2014 Aug 21;33(34):4330-9.
4 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
5 Targeting 3-phosphoinoside-dependent kinase-1 to inhibit insulin-like growth factor-I induced AKT and p70 S6 kinase activation in breast cancer cells. PLoS One. 2012;7(10):e48402.
6 Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor. Mol Cancer Ther. 2010 Mar;9(3):706-17.
7 2,3,5-Trisubstituted pyridines as selective AKT inhibitors. Part II: Improved drug-like properties and kinase selectivity from azaindazoles. Bioorg Med Chem Lett. 2010 Jan 15;20(2):679-83.